학술논문
200P - Apalutamide (APA) plus androgen deprivation therapy (ADT) for metastatic castration-sensitive prostate cancer (mCSPC): Analysis of pain and fatigue in the TITAN study
Document Type
Abstract
Author
Source
In Annals of Oncology November 2019 30 Supplement 9:ix68-ix68
Subject
Language
ISSN
0923-7534